Tuesday, January 17, 2012
Redesign Strengthens Resource for Pharmaceutical Professionals and Drives Value for Advertisers
SOUTH SAN FRANCISCO, CA--(Marketwire - Jan 17, 2012) - American Pharmaceutical Review, the leading review of business and technology for the pharmaceutical industry and a business unit of CompareNetworks, Inc., today announced the launch of their newly redesigned website, http://americanpharmaceuticalreview.com.
The new American Pharmaceutical Review website features:
"I'm very proud to unveil the new American Pharmaceutical Review website," said Nigel Russell, General Manager of American Pharmaceutical Review. "By combining technical articles with detailed product and service information we're able to provide the ultimate resource for the pharmaceutical industry. At every stage of the buying cycle, professionals can now turn to American Pharmaceutical Review to make more informed purchasing decisions."
American Pharmaceutical Review has also enhanced its online advertising platform through increased ad space, product visibility and lead generation capabilities. "At American Pharmaceutical Review, our goal is to put the needs of both pharmaceutical professionals and our advertising partners first," said Bo Purtic, Ph.D., MBA, Chief Revenue Officer for CompareNetworks. "The redesign improves user experience which ultimately delivers more value to marketers. We're positive this redesign achieves our objectives."
American Pharmaceutical Review
Headquartered in South San Francisco, California, American Pharmaceutical Review is a subsidiary of CompareNetworks, Inc. a leading global media company that empowers scientists and healthcare professionals with online marketplaces to enhance their productivity. American Pharmaceutical Review offers unbiased editorial on drug delivery, information technology, research & development, analytical development and control, equipment and facility manufacturing and regulatory affairs. American Pharmaceutical Review keeps its subscribers and online users including senior executives, technical personnel, scientists, and others fully abreast of the latest trends and developments in the process of pharmaceutical manufacturing.